180 related articles for article (PubMed ID: 28199203)
1. Neurogenetics of acute and chronic opiate/opioid abstinence: treating symptoms and the cause.
Blum K; Gold MS; Jacobs W; McCall WV; Febo M; Baron D; Dushaj K; Demetrovics Z; Badgaiyan RD
Front Biosci (Landmark Ed); 2017 Mar; 22(8):1247-1288. PubMed ID: 28199203
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal.
Scavone JL; Sterling RC; Van Bockstaele EJ
Neuroscience; 2013 Sep; 248():637-54. PubMed ID: 23624062
[TBL] [Abstract][Full Text] [Related]
3. The role of neurotransmitters in alcohol dependence: animal research.
De Witte P
Alcohol Alcohol; 1996 Mar; 31 Suppl 1():13-6. PubMed ID: 8736996
[TBL] [Abstract][Full Text] [Related]
4. [Neurobiological mechanisms and interventions in drug craving after withdrawal].
Lu L; Wang X; Luo YX; Zhang XL; Shi J
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Jun; 41(3):282-4. PubMed ID: 19727209
[TBL] [Abstract][Full Text] [Related]
5. Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports.
Miller DK; Bowirrat A; Manka M; Miller M; Stokes S; Manka D; Allen C; Gant C; Downs BW; Smolen A; Stevens E; Yeldandi S; Blum K
Postgrad Med; 2010 Nov; 122(6):188-213. PubMed ID: 21084795
[TBL] [Abstract][Full Text] [Related]
6. Molecular neurological correlates of endorphinergic/dopaminergic mechanisms in reward circuitry linked to endorphinergic deficiency syndrome (EDS).
Blum K; Baron D; McLaughlin T; Gold MS
J Neurol Sci; 2020 Apr; 411():116733. PubMed ID: 32088516
[TBL] [Abstract][Full Text] [Related]
7. Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal.
Watkins SS; Koob GF; Markou A
Nicotine Tob Res; 2000 Feb; 2(1):19-37. PubMed ID: 11072438
[TBL] [Abstract][Full Text] [Related]
8. A thalamic input to the nucleus accumbens mediates opiate dependence.
Zhu Y; Wienecke CF; Nachtrab G; Chen X
Nature; 2016 Feb; 530(7589):219-22. PubMed ID: 26840481
[TBL] [Abstract][Full Text] [Related]
9. Relapse to opioid seeking in rat models: behavior, pharmacology and circuits.
Reiner DJ; Fredriksson I; Lofaro OM; Bossert JM; Shaham Y
Neuropsychopharmacology; 2019 Feb; 44(3):465-477. PubMed ID: 30293087
[TBL] [Abstract][Full Text] [Related]
10. Reward deficiency syndrome: genetic aspects of behavioral disorders.
Comings DE; Blum K
Prog Brain Res; 2000; 126():325-41. PubMed ID: 11105655
[TBL] [Abstract][Full Text] [Related]
11. Rationale for maintenance pharmacotherapy of opiate dependence.
Kreek MJ
Res Publ Assoc Res Nerv Ment Dis; 1992; 70():205-30. PubMed ID: 1346939
[TBL] [Abstract][Full Text] [Related]
12. Fifty Years in the Development of a Glutaminergic-Dopaminergic Optimization Complex (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome: A Pictorial.
Blum K; Febo M; Badgaiyan RD
Austin Addict Sci; 2016; 1(2):. PubMed ID: 27840857
[TBL] [Abstract][Full Text] [Related]
13. Benzodiazepine co-dependence exacerbates the opiate withdrawal syndrome.
de Wet C; Reed L; Glasper A; Moran P; Bearn J; Gossop M
Drug Alcohol Depend; 2004 Oct; 76(1):31-5. PubMed ID: 15380286
[TBL] [Abstract][Full Text] [Related]
14. Distinct mu, delta, and kappa opioid receptor mechanisms underlie low sociability and depressive-like behaviors during heroin abstinence.
Lutz PE; Ayranci G; Chu-Sin-Chung P; Matifas A; Koebel P; Filliol D; Befort K; Ouagazzal AM; Kieffer BL
Neuropsychopharmacology; 2014 Oct; 39(11):2694-705. PubMed ID: 24874714
[TBL] [Abstract][Full Text] [Related]
15. Opioid abuse and brain gene expression.
Przewlocki R
Eur J Pharmacol; 2004 Oct; 500(1-3):331-49. PubMed ID: 15464044
[TBL] [Abstract][Full Text] [Related]
16. Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management.
Pergolizzi JV; Raffa RB; Rosenblatt MH
J Clin Pharm Ther; 2020 Oct; 45(5):892-903. PubMed ID: 31986228
[TBL] [Abstract][Full Text] [Related]
17. CRF2 Receptor Deficiency Eliminates the Long-Lasting Vulnerability of Motivational States Induced by Opiate Withdrawal.
Morisot N; Rouibi K; Contarino A
Neuropsychopharmacology; 2015 Jul; 40(8):1990-2000. PubMed ID: 25672976
[TBL] [Abstract][Full Text] [Related]
18. The motivational component of withdrawal in opiate addiction: role of associative learning and aversive memory in opiate addiction from a behavioral, anatomical and functional perspective.
Frenois F; Le Moine C; Cador M
Rev Neurosci; 2005; 16(3):255-76. PubMed ID: 16323564
[TBL] [Abstract][Full Text] [Related]
19. Morphofunctional alterations in ventral tegmental area dopamine neurons in acute and prolonged opiates withdrawal. A computational perspective.
Enrico P; Migliore M; Spiga S; Mulas G; Caboni F; Diana M
Neuroscience; 2016 May; 322():195-207. PubMed ID: 26899424
[TBL] [Abstract][Full Text] [Related]
20. Cerebral monoamine neurotransmitters in opioid withdrawal and dependence.
Ahtee L; Attila LM
Med Biol; 1987; 65(2-3):113-9. PubMed ID: 2888928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
